Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
45
JXFGF Quote, Financials, Valuation and Earnings
Last price:
$0.29
Seasonality move
:
-6.2%
Day range:
$0.29 - $0.29
52-week range:
$0.28 - $0.49
Dividend yield:
0%
P/E ratio:
50.00x
P/S ratio:
2.14x
P/B ratio:
0.55x
Volume:
--
Avg. volume:
100
1-year change:
-40.82%
Market cap:
$796M
Revenue:
$390.7M
EPS (TTM):
-$0.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
-- | -- | -- | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -$0.34 | -- | -- | $9.22 |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$138M | -$0.28 | 16.92% | -46.43% | $49.49 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
$0.29 | -- | $796M | 50.00x | $0.01 | 0% | 2.14x |
|
ADAG
Adagene, Inc.
|
$1.86 | $9.22 | $87.6M | -- | $0.00 | 0% | 837.10x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$0.84 | $4.00 | $17.3M | -- | $0.00 | 0% | 0.49x |
|
CPHI
China Pharma Holdings, Inc.
|
$1.35 | -- | $4.4M | -- | $0.00 | 0% | 1.09x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
ZLAB
Zai Lab Ltd.
|
$17.22 | $49.49 | $1.9B | -- | $0.00 | 0% | 4.18x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
16.67% | -1.202 | -- | 0.49x |
|
ADAG
Adagene, Inc.
|
26.49% | 2.508 | -- | 2.23x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | 0.019 | 55.28% | 0.19x |
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.772 | 56.09% | 0.09x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.067 | 12.91% | 11.22x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | 0.005 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JXFGF
Jinxin Fertility Group Ltd.
|
-- | -- | 2.51% | 3.05% | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -- | -42.07% | -56.44% | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Jinxin Fertility Group Ltd. vs. Competitors
-
Which has Higher Returns JXFGF or ADAG?
Adagene, Inc. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of --. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Adagene, Inc.'s return on equity of -56.44%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B ADAGAdagene, Inc.-- -- $68.7M -
What do Analysts Say About JXFGF or ADAG?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Adagene, Inc. has an analysts' consensus of $9.22 which suggests that it could grow by 395.93%. Given that Adagene, Inc. has higher upside potential than Jinxin Fertility Group Ltd., analysts believe Adagene, Inc. is more attractive than Jinxin Fertility Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 ADAGAdagene, Inc.6 2 0 -
Is JXFGF or ADAG More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Adagene, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JXFGF or ADAG?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Adagene, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Adagene, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or ADAG?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Adagene, Inc. quarterly revenues of --. Jinxin Fertility Group Ltd.'s net income of -- is lower than Adagene, Inc.'s net income of --. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Adagene, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 837.10x for Adagene, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- ADAGAdagene, Inc.837.10x -- -- --
-
Which has Higher Returns JXFGF or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of -353.92%. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About JXFGF or CASI?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 375%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Jinxin Fertility Group Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Jinxin Fertility Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is JXFGF or CASI More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.657%.
-
Which is a Better Dividend Stock JXFGF or CASI?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or CASI?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Jinxin Fertility Group Ltd.'s net income of -- is lower than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 0.49x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- CASICASI Pharmaceuticals, Inc.0.49x -- $3.1M -$10.9M
-
Which has Higher Returns JXFGF or CPHI?
China Pharma Holdings, Inc. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of -86.16%. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat China Pharma Holdings, Inc.'s return on equity of -43.41%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M -
What do Analysts Say About JXFGF or CPHI?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand China Pharma Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jinxin Fertility Group Ltd. has higher upside potential than China Pharma Holdings, Inc., analysts believe Jinxin Fertility Group Ltd. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 CPHIChina Pharma Holdings, Inc.0 0 0 -
Is JXFGF or CPHI More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison China Pharma Holdings, Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.826%.
-
Which is a Better Dividend Stock JXFGF or CPHI?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. China Pharma Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. China Pharma Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or CPHI?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than China Pharma Holdings, Inc. quarterly revenues of $756.2K. Jinxin Fertility Group Ltd.'s net income of -- is lower than China Pharma Holdings, Inc.'s net income of -$651.5K. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while China Pharma Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 1.09x for China Pharma Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- CPHIChina Pharma Holdings, Inc.1.09x -- $756.2K -$651.5K
-
Which has Higher Returns JXFGF or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of --. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About JXFGF or SVA?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Jinxin Fertility Group Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Jinxin Fertility Group Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is JXFGF or SVA More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.723, suggesting its less volatile than the S&P 500 by 27.741%.
-
Which is a Better Dividend Stock JXFGF or SVA?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or SVA?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Jinxin Fertility Group Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns JXFGF or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Jinxin Fertility Group Ltd.'s net margin of -30.98%. Jinxin Fertility Group Ltd.'s return on equity of 3.05% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital JXFGFJinxin Fertility Group Ltd.-- -- $1.7B ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About JXFGF or ZLAB?
Jinxin Fertility Group Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Zai Lab Ltd. has an analysts' consensus of $49.49 which suggests that it could grow by 187.39%. Given that Zai Lab Ltd. has higher upside potential than Jinxin Fertility Group Ltd., analysts believe Zai Lab Ltd. is more attractive than Jinxin Fertility Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings JXFGFJinxin Fertility Group Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is JXFGF or ZLAB More Risky?
Jinxin Fertility Group Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.872, suggesting its less volatile than the S&P 500 by 12.778%.
-
Which is a Better Dividend Stock JXFGF or ZLAB?
Jinxin Fertility Group Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jinxin Fertility Group Ltd. pays -- of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JXFGF or ZLAB?
Jinxin Fertility Group Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Jinxin Fertility Group Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$36M. Notably, Jinxin Fertility Group Ltd.'s price-to-earnings ratio is 50.00x while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jinxin Fertility Group Ltd. is 2.14x versus 4.18x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JXFGFJinxin Fertility Group Ltd.2.14x 50.00x -- -- ZLABZai Lab Ltd.4.18x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 37x
Alerts
Sell
46
BE alert for Dec 18
Bloom Energy Corp. [BE] is up 4.27% over the past day.
Sell
44
STRL alert for Dec 18
Sterling Infrastructure, Inc. [STRL] is up 6.62% over the past day.
Sell
39
SOXL alert for Dec 18
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 7.28% over the past day.
